Adams Respiratory Therapeutics, Inc. (ARXT) is a publicly traded company in the Unknown sector. Across all available filings, 22 corporate insiders have executed 908 transactions totaling $109.8M, demonstrating a bearish sentiment with -$109.7M in net insider flow. The most recent transaction on Jan 29, 2008 involved a transaction of 2,709 shares valued at $162.5K.
No significant insider buying has been recorded for ARXT in the recent period.
No significant insider selling has been recorded for ARXT in the recent period.
Based on recent SEC filings, insider sentiment for ARXT is bearish with an Insider Alignment Score of 0/100 and a net flow of -$109.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Adams Respiratory Therapeutics, Inc. (ARXT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 22 insiders are actively trading ARXT stock, having executed 908 transactions in the past 90 days. The most active insider is Investments Llc Sz (Executive), who has made 1 transactions totaling $57.3M.
Get notified when executives and directors at ARXT file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 29, 2008 | Albrecht Helmut | Executive | Disposition | 2,709 | $60.00 | $162.5K | |
| Jan 29, 2008 | K. Calhoun Kirk | Executive | Disposition | 3,184 | $60.00 | $191.0K | |
| Jan 29, 2008 | Daniel Casale Robert | Executive | Disposition | 8,579 | $60.00 | $514.7K | Large |
| Jan 29, 2008 | L. Delgado Jane | Executive | Disposition | 1,072 | $60.00 | $64.3K | |
| Jan 29, 2008 | W. Dunton Alan | Executive | Disposition | 1,623 | $60.00 | $97.4K | |
| Jan 29, 2008 | J. Liebentritt Donald | Executive | Disposition | 3,675 | $60.00 | $220.5K | |
| Jan 29, 2008 | N. Lilly John | Executive | Disposition | 3,038 | $60.00 | $182.3K | |
| Jan 29, 2008 | P. Neuscheler Joan | Executive | Disposition | 3,675 | $60.00 | $220.5K | |
| Jan 29, 2008 | F. Oberkfell Harold | Executive | Disposition | 3,675 | $60.00 | $220.5K | |
| Jan 29, 2008 | M. O'connor Rita | Executive | Disposition | 7,225 | $60.00 | $433.5K | |
| Jan 29, 2008 | E. Riehemann Walter | Executive | Disposition | 4,515 | $60.00 | $270.9K | |
| Jan 29, 2008 | R. Sotir Mark | Executive | Disposition | 1,072 | $60.00 | $64.3K | |
| Jan 29, 2008 | Thievon John | Executive | Disposition | 4,515 | $60.00 | $270.9K | |
| Jan 29, 2008 | J. Valentino Michael | Executive | Disposition | 14,179 | $60.00 | $850.7K | Large |
| Jan 29, 2008 | D. Wentworth Peter | Executive | Disposition | 4,741 | $60.00 | $284.5K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 674 | $109.7M | 84.3% |
Tender(U) | 17 | $14.5M | 11.2% |
Disposition(D) | 15 | $4.0M | 3.1% |
Exercise(M) | 91 | $1.8M | 1.4% |
Purchase(P) | 1 | $30.1K | 0.0% |
Other(J) | 34 | $0 | 0.0% |
Award(A) | 73 | $0 | 0.0% |
Gift(G) | 3 | $0 | 0.0% |
Insider selling pressure at Adams Respiratory Therapeutics, Inc. has increased, with 22 insiders executing 908 transactions across all time. Total sales of $109.7M significantly outpace purchases of $30.1K, resulting in a net outflow of $109.7M. This selling activity appears largely discretionary, which may warrant closer attention from investors.